# G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

> **NCT03793205** · PHASE4 · UNKNOWN · sponsor: **Lei Li** · enrollment: 100 (estimated)

## Conditions studied

- Gynecologic Cancer
- Myelosuppression Adult
- Febrile Neutropenia
- Chemotherapy-induced Neutropenia

## Interventions

- **DRUG:** Long-acting G-CSF
- **DRUG:** Short-acting G-CSF

## Key facts

- **NCT ID:** NCT03793205
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-03
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03793205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03793205, "G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03793205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*